DBV Technologies (DBVT) FCF Margin Growth (1y) (2021 - 2026)
DBV Technologies (DBVT) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -531,143.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -531,143.00 |
| Mar 31, 2026 | -303,750.00 |
| Dec 31, 2025 | -334,547.00 |
| Sep 30, 2025 | 95,780.00 |
| Jun 30, 2025 | 82,398.00 |
| Mar 31, 2025 | 9,805.00 |
| Dec 31, 2024 | -200,736.00 |
| Sep 30, 2024 | -130,453.00 |
| Jun 30, 2024 | -195,998.00 |
| Mar 31, 2024 | -160,559.00 |
| Dec 31, 2023 | -199,077.00 |
| Sep 30, 2023 | 15,734.00 |
| Jun 30, 2023 | -43,806.00 |
| Mar 31, 2023 | -89,157.00 |
| Dec 31, 2022 | 250,449.00 |
| Sep 30, 2022 | 74,902.00 |
| Jun 30, 2022 | 133,879.00 |
| Mar 31, 2022 | 117,387.00 |
| Dec 31, 2021 | -343,848.00 |
| Sep 30, 2021 | -71,805.00 |